Newberry hired as director of Taylor House

Aspirus Health is proud to announce the successful introduction of the TriClip G4 System, the first FDA-approved technology that allows physicians to repair the tricuspid valve without open-heart surgery. The device, approved by the U.S. Food and Drug Administration on April 4, 2024, offers a groundbreaking, minimally invasive treatment option for patients with tricuspid valve disease.The tricuspi...